Mucus plugs affect some 40% to nearly 70% of COPD patients, and even clinically silent mucus plugs are linked to poorer ...

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States, most often caused by ...

Researchers say they've discovered an already approved migraine drug that can stop symptoms hours before a severe headache ...

There is significant risk for subsequent stroke in patients hospitalized for acute exacerbation of COPD with atrial fibrillation.

Expect to report topline data from the Seabreeze STAT COPD study in 1H 2026 – SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect ...

The global COPD therapeutics market is on a robust growth trajectory, having achieved a market valuation of USD 12,144.1 million in 2023, and is projected to reach USD 20,035.5 million by 2033, ...